You are here

Articles

CML Horizons 2024 Videos and Presentations

published: 5 July 2024

iCMLf Publicaions.

published: 4 May 2023

iCMLf Forum 2022: The Next Big Challenges in CML? Webstreams

published: 4 March 2023

iCMLf publications: A selection of interesting articles on CML from peer-reviewed journals

published: 13 February 2023

iCMLf Conversation- Treatment of CML patients after failure of 2 TKIs

published: 23 July 2022

iCMLf- Highlights of EHA 2022

published: 28 June 2022

iCMLf Newsletter 2022

published: 16 June 2022

TFR in chronic myeloid leukemia: Lights and shadows. In several studies, NK cell numbers or functional subsets of NK cells were shown to be higher in patients who maintain TFR

published: 26 March 2022

Discontinuation of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: a Review of the Biological Factors Associated with Treatment-Free Remission

published: 1 March 2022

Top Vitamin D Research Papers- 2021

published: 23 February 2022

63rd ASH Annual Meeting - CMLAdNet Conference Report

published: 21 February 2022

2021’s Top 10 Blogs from GrassrootsHealth:

published: 30 December 2021

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

published: 30 December 2021

Taming the gatekeeper: ponatinib dose holds the key

published: 3 December 2021

CML Highlights of the 63rd ASH Annual Meeting

published: 24 November 2021

iCMLf : CML Knowledge Centre

published: 7 October 2021

Vit D -The story behind the Beginning of D*action

published: 1 October 2021

Results from ACEMBL Trial - Aciminib vs Bosutinib

published: 7 September 2021

Treatment-Free Remission in Chronic Myeloid Leukemia: Can We Identify Prognostic Factors?

published: 7 September 2021

Long-term follow-up of lower dose dasatinib (50 mg daily)

published: 3 September 2021